1. Home
  2. EBF vs EOLS Comparison

EBF vs EOLS Comparison

Compare EBF & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ennis Inc.

EBF

Ennis Inc.

HOLD

Current Price

$18.28

Market Cap

467.2M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.16

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBF
EOLS
Founded
1909
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.2M
444.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
EBF
EOLS
Price
$18.28
$7.16
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.80
AVG Volume (30 Days)
234.5K
959.0K
Earning Date
12-22-2025
11-05-2025
Dividend Yield
5.53%
N/A
EPS Growth
4.41
N/A
EPS
1.66
N/A
Revenue
$388,740,000.00
$285,823,000.00
Revenue This Year
$0.96
$14.36
Revenue Next Year
N/A
$23.27
P/E Ratio
$10.89
N/A
Revenue Growth
N/A
15.10
52 Week Low
$16.30
$5.71
52 Week High
$22.01
$17.12

Technical Indicators

Market Signals
Indicator
EBF
EOLS
Relative Strength Index (RSI) 59.17 55.75
Support Level $17.89 $7.01
Resistance Level $18.47 $7.34
Average True Range (ATR) 0.42 0.23
MACD 0.03 0.02
Stochastic Oscillator 52.31 82.21

Price Performance

Historical Comparison
EBF
EOLS

About EBF Ennis Inc.

Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: